Medically Reviewed and Compiled by Dr. Adam N. Khan, MD.
Quick Summary:
- Yes, dogs can get the flu: Canine influenza (dog flu) is a highly contagious viral respiratory infection caused by specific Type A influenza strains (H3N2 and H3N8).
- Key Symptoms: Infection causes a persistent cough, nasal and eye discharge, fever, lethargy, and loss of appetite, with roughly 80% of exposed dogs showing symptoms.
- Recovery and Prevention: Most dogs recover in 2 to 3 weeks with supportive care, but high-risk dogs need close monitoring to prevent secondary bacterial pneumonia. Isolation and bivalent vaccines offer strong protection.
EMERGENCY WARNING: If your dog displays blue, purple, or pale gums, rapid or severely labored breathing, extreme collapse, high fever exceeding 104°F (40°C), coughing up bright red blood, or complete inability to keep fluids down, seek immediate emergency veterinary medical care. These red-flag signs indicate acute respiratory distress or severe pneumonia requiring urgent emergency evaluation and oxygen support.
Medical Overview and Pathophysiology of Canine Influenza
Canine influenza, commonly known as “dog flu,” is a contagious respiratory infection caused by specific influenza A viruses that infect dogs. Pet owners often wonder whether human flu strains can cross over to their canine companions or vice versa. While dogs do contract viral influenza, the viruses responsible for canine influenza are genetically distinct from the seasonal influenza strains that infect humans.
The primary strains responsible for dog flu outbreaks are canine influenza virus (CIV) strains H3N8 and H3N2.
- H3N8 Strain: Historically originated in horses (equine influenza) and jumped to dogs in 2004, adapting to spread directly from dog to dog.
- H3N2 Strain: Originated in avian species (birds) in Asia, adapted to canines, and was introduced into North America in 2015. It remains the dominant circulating strain during regional outbreaks.
Pathophysiologically, the canine influenza virus targets and replicates within the epithelial cells lining the upper and lower respiratory tract. The virus invades the mucosal surfaces of the nasal passages, trachea, bronchi, and bronchioles. As the virus replicates, it destroys the protective ciliated cells responsible for clearing mucus and foreign debris from the airway. This cellular destruction triggers an acute inflammatory cascade, causing local swelling, increased mucus production, and airway hypersensitivity.
Because the natural protective clearing mechanisms of the trachea and lungs are temporarily damaged, infected dogs become uniquely vulnerable to secondary bacterial infections. Bacteria like Bordetella bronchiseptica, Streptococcus, or Mycoplasma species can take advantage of the viral damage, traveling deeper into the lungs and causing bacterial pneumonia.
Canine influenza spreads through airborne respiratory droplets generated when infected dogs cough, sneeze, or bark. It also spreads via direct contact (such as nose-to-nose greeting or nuzzling) and indirect contact with contaminated surfaces (fomites). Water bowls, food dishes, kennels, leashes, and human hands or clothing can harbour viable viral particles.
The virus can remain infectious on non-porous hard surfaces for up to 48 hours, on clothing for 24 hours, and on unwashed human hands for up to 12 hours. Because dogs lack natural baseline immunity to newly introduced viral strains, virtually 100% of exposed, unvaccinated dogs become infected upon exposure, with approximately 80% exhibiting clinical illness.
Symptom Breakdown and Diagnostic Comparison Table
Recognizing canine influenza early requires distinguishing its clinical presentation from other common canine respiratory diseases, most notably the Canine Infectious Respiratory Disease Complex (CIRDC), commonly known as “kennel cough”.
Kennel cough is an umbrella term for respiratory infections caused by various viral and bacterial agents, including Canine Parainfluenza Virus, Canine Adenovirus Type 2, and Bordetella bronchiseptica. While the clinical presentations overlap, canine influenza tends to cause systemic symptoms like high fever, severe fatigue, and systemic malaise more frequently than standard kennel cough.
+-------------------+----------------------------+----------------------------+----------------------------+
| Clinical Feature | Canine Influenza (H3N2/H3N8)| Classic Kennel Cough | Secondary Bacterial Pneumonia|
+-------------------+----------------------------+----------------------------+----------------------------+
| Primary Cough | Moist or dry, persistent | Dry, harsh, honking cough | Deep, wet, rattling cough |
| Type | lasting 10 to 21 days | with terminal gagging | with painful breathing |
+-------------------+----------------------------+----------------------------+----------------------------+
| Onset Speed | Rapid (2 to 4 days post | Gradual (3 to 10 days post | Secondary progression |
| | exposure) | exposure) | after 4 to 7 days of flu |
+-------------------+----------------------------+----------------------------+----------------------------+
| Fever Presence | Low to high fever | Rare; usually normal | High persistent fever |
| | (102.5°F to 105°F) | temperature | (exceeding 103.5°F) |
+-------------------+----------------------------+----------------------------+----------------------------+
| Nasal Discharge | Clear initially, becoming | Mild, clear nasal discharge| Thick, yellow-green, |
| | thick and mucopurulent | or none | purulent discharge |
+-------------------+----------------------------+----------------------------+----------------------------+
| Energy & Appetite | Moderate to severe | Usually normal energy and | Severe lethargy, complete |
| | lethargy; reduced appetite | active appetite | anorexia, severe weakness |
+-------------------+----------------------------+----------------------------+----------------------------+
| Duration | 2 to 3 weeks | 7 to 14 days | Requires 3 to 6+ weeks |
| | | | of active treatment |
+-------------------+----------------------------+----------------------------+----------------------------+
| Contagiousness | Extremely high; air and | Moderate to high in | Secondary complication; |
| | surface transmission | direct contact settings | underlying virus spreads |
+-------------------+----------------------------+----------------------------+----------------------------+
Detailed Symptom Descriptions
- Persistent Cough: The hallmark clinical sign is a persistent cough that lasts between 10 and 21 days despite early symptomatic intervention. The cough can present either as a dry, hacking rasp or a moist, productive cough.
- Nasal and Ocular Discharge: Early in the illness, dogs develop clear watery discharge from both eyes and nasal passages. As cellular breakdown progresses, the nasal discharge often thickens, changing to a yellow-green color.
- Fever: Elevated core body temperature is common during the acute viral replication phase. A normal dog’s temperature ranges between 101.0°F and 102.5°F. Dogs with flu often exhibit fevers ranging from 103.0°F to 105.0°F.
- Lethargy and Anorexia: Infected dogs display noticeable systemic depression, decreased interest in daily play, reluctance to walk, and significant loss of appetite.
- Subclinical Infection (Asymptomatic Carriers): Approximately 20% of dogs infected with the canine influenza virus show no outward clinical signs. However, these asymptomatic dogs shed active viral particles in their respiratory secretions, making them silent vectors within dog daycares, shelters, and parks.
Unique Clinical Takeaways
To provide actionable veterinary guidance beyond standard symptom summaries, consider these key clinical insights:
- Extended Shedding Windows Require Extended Isolation: The H3N2 strain exhibits a significantly longer viral shedding duration than typical canine respiratory viruses. While dogs infected with the H3N8 strain or standard kennel cough typically stop shedding viral particles within 7 to 10 days, dogs infected with H3N2 can shed live, infectious virus for up to 24 to 28 days post-exposure—even after clinical signs like coughing have completely resolved. Reintroducing a pet to dog parks or daycare after a standard 10-day quarantine can accidentally spark community outbreaks. Isolation protocols for suspected H3N2 cases must strictly extend to 21–28 days.
- The “Diagnostic PCR Window” Misalignment: Reverse Transcription-Polymerase Chain Reaction (RT-PCR) nasal swab testing is the gold standard for confirming viral RNA. However, viral shedding in the upper nasal passages peaks during the early incubation period (days 1 to 4 post-exposure) and declines rapidly once the dog develops a strong cough and fever. Testing a dog that has been coughing for more than 7 days frequently yields a false-negative PCR result because the viral load in the nasal mucosa has dropped. For dogs sick longer than a week, veterinary diagnostic plans must pivot to serological testing (Hemagglutination Inhibition paired acute and convalescent blood samples) rather than relying solely on mucosal swabs.
- Interspecies Transmission Risk to Cats: While canine influenza viruses do not pose a threat to human health, the H3N2 strain has demonstrated a documented capacity for interspecies transmission from infected dogs to domestic cats. Cats infected with H3N2 can develop upper respiratory symptoms, including severe nasal discharge, salivation, lethargy, and sneezing. In households with both dogs and cats, an isolated dog must also be kept at least 20 feet away from feline companions to prevent cross-species transmission.
Day-by-Day Illness Progression Timeline
Understanding the typical timeline of canine influenza helps pet parents monitor their dog’s recovery and spot warning signs early.
+-----------------------------------------------------------------------------------+
| DAY 1 - DAY 3: Incubation & Early Viral Replication |
| - Exposure occurs; virus invades nasal and tracheal epithelial cells. |
| - Incubation lasts 2 to 4 days (H3N8) or 2 to 8 days (H3N2). |
| - Dog is contagious and actively shedding virus before showing symptoms. |
+-----------------------------------------------------------------------------------+
|
v
+-----------------------------------------------------------------------------------+
| DAY 4 - DAY 7: Acute Clinical Onset |
| - Sudden onset of persistent, dry or moist cough. |
| - Clear ocular and nasal discharge develops. |
| - Low to moderate fever (103°F-104.5°F), lethargy, and decreased appetite. |
| - Optimal window for diagnostic nasal PCR swab collection. |
+-----------------------------------------------------------------------------------+
|
v
+-----------------------------------------------------------------------------------+
| DAY 8 - DAY 14: Symptomatic Peak & Immune Response |
| - Viral replication wanes; immune antibody response mounts. |
| - Cough remains persistent; nasal discharge may thicken. |
| - CRITICAL WINDOW: Monitor closely for secondary bacterial pneumonia. |
| - High-risk dogs may experience respiratory distress if complications arise. |
+-----------------------------------------------------------------------------------+
|
v
+-----------------------------------------------------------------------------------+
| DAY 15 - DAY 28: Convalescence & Continued Quarantine |
| - Fever resolves; energy and appetite gradually return to baseline. |
| - Mild, intermittent cough may persist due to tracheal healing. |
| - H3N2 shedding can persist up to Day 24-28; strict quarantine must continue. |
| - Full respiratory mucosa repair achieved by weeks 3 to 4. |
+-----------------------------------------------------------------------------------+
High-Risk Vulnerabilities and Special Populations
While canine influenza can infect dogs of any age, breed, or health status, specific canine populations face a higher risk of developing severe complications such as bacterial pneumonia, respiratory distress, and hospitalization.
Brachycephalic (Flat-Faced) Breeds
Breeds such as Bulldogs, Pugs, Boston Terriers, French Bulldogs, and Shih Tzus have anatomical variations known as Brachycephalic Ocular and Airway Syndrome (BOAS). Their shortened cranial bones result in narrowed nostrils (stenotic nares), elongated soft palates, and reduced tracheal diameters.
When canine influenza causes mucosal inflammation and swelling in the upper airways, these dogs experience severe airway resistance. The increased work of breathing can lead to acute respiratory distress, hyperthermia, and collapse far more rapidly than in non-brachycephalic breeds.
Senior Dogs (Aged 8+ Years)
Aging in dogs is accompanied by immunosenescence—a gradual decline in immune system efficiency. Senior dogs often have co-existing chronic health conditions such as degenerative heart disease, chronic kidney disease, or preexisting collapse of the trachea.
When exposed to canine influenza, senior dogs struggle to mount a rapid viral-clearing antibody response. The added stress of systemic fever and hypoxia can worsen underlying heart or kidney disease, leading to secondary organ stress.
Puppies and Pediatric Canines
Immature puppies have developing immune systems that have not yet achieved full immunocompetence. Additionally, their small airway diameters make them prone to airway obstruction when dense, mucopurulent secretions accumulate. Puppies are also at heightened risk for rapid dehydration when fever and decreased nursing or water intake occur concurrently.
Immunocompromised Dogs
Dogs receiving immunosuppressive therapies (such as chronic prednisone, cyclosporine, or chemotherapy for cancer) or those suffering from underlying autoimmune disorders are unable to effectively clear viral infections. In these patients, viral replication can proceed uninhibited, destroying large sections of pulmonary tissue and increasing susceptibility to multi-bacterial lung infections.
Evidence-Based Diagnostic, Testing, and Medical Management Guidelines
Diagnosing canine influenza requires professional veterinary evaluation, as the symptoms cannot be reliably distinguished from other respiratory pathogens by physical exam alone.
Suspected Canine Influenza Case
|
+------------------+------------------+
| |
Symptom Duration < 7 Days Symptom Duration > 7 Days
| |
Deep Nasal / Pharyngeal Serology Blood Testing
Respiratory PCR Panel (Acute & Convalescent HI)
| |
Confirm Strain Confirm Retrospective
(H3N2 vs. H3N8) Antibody Titer
| |
+------------------+------------------+
|
Clinical Severity Risk
|
+------------------+------------------+
| |
Mild / Uncomplicated Severe / Complicated
| |
Outpatient Supportive Care Inpatient Hospitalization
- Rest & Hydration - Oxygen Therapy
- Environmental Humidification - IV Fluid Administration
- Cough Suppressants (if non-productive)- Targeted IV Antibiotics
- 21 to 28 Day Isolation - Nebulization & Coupage
Diagnostic Protocols
- Respiratory PCR Panels: For dogs presenting within 1 to 4 days of symptom onset, veterinarians take deep nasal or pharyngeal swabs to submit for real-time PCR testing. Comprehensive panels test simultaneously for CIV H3N2, CIV H3N8, Canine Parainfluenza, Adenovirus, Bordetella, and Mycoplasma.
- Serology (Hemagglutination Inhibition): If a dog has been coughing for longer than 7 days, nasal PCR swabs may return false negatives due to reduced viral shedding. Serum blood samples collected during the acute phase and repeated 14 days later (convalescent phase) confirm infection if there is a four-fold rise in antibody titers.
- Thoracic Radiographs (Chest X-Rays): If a dog exhibits high fever, rapid breathing, or abnormal lung sounds (crackles or wheezes), chest X-rays are crucial to evaluate for bronchopneumonia, lobar consolidation, or fluid accumulation.
Medical Management
There are no specific antiviral medications approved for canine influenza; treatment relies on supportive care tailored to symptom severity.
- Uncomplicated Mild Cases: Treated on an outpatient basis. Treatment includes strict physical rest, high-palatability nutrition, and encouraging fluid intake. Non-steroidal anti-inflammatory drugs (NSAIDs) approved for canines (such as carprofen or meloxicam) may be prescribed by a veterinarian to control high fevers and reduce throat inflammation. Never administer human medications like acetaminophen, aspirin, or ibuprofen, as these are highly toxic or fatal to dogs.
- Managing Secondary Bacterial Complications: Antibiotics are ineffective against viral infections and should not be used routinely for mild, uncomplicated flu. However, if a dog develops signs of secondary bacterial infection—such as mucopurulent yellow-green discharge, persistent fever, lethargy, or radiographic evidence of pneumonia—broad-spectrum antibiotics (e.g., doxycycline, amoxicillin-clavulanate, or fluoroquinolones) are prescribed.
- Severe Inpatient Hospitalization: Severe cases with bacterial pneumonia require intensive veterinary hospital care. Interventions include oxygen therapy via nasal cannulas or oxygen cages, intravenous fluid support to correct dehydration and thin respiratory secretions, nebulization therapy with saline to open airways, and gentle chest physiotherapy (coupage) to help clear pulmonary secretions.
Home Care, Isolation Protocols, and Prevention
Managing an infected dog at home requires rigorous hygiene and isolation practices to support recovery and prevent the virus from spreading throughout the household and community.
Home Care Practices
- Environmental Humidification: Place a cool-mist humidifier near your dog’s sleeping area. Adding moisture to the air soothes inflamed airway passages and thins thick respiratory secretions, making them easier to clear. Alternatively, bringing your dog into a steamy bathroom while you run a warm shower can provide relief.
- Harness Use Over Neck Collars: Avoid using neck collars or attach leashes exclusively to a chest harness during the recovery period. Pressure from a neck collar on an inflamed trachea triggers coughing fits and worsens mechanical irritation.
- Nutritional Encouragement: Sick dogs often suffer from a reduced sense of smell and a painful throat, leading to loss of appetite. Offer warm, soft foods such as boiled chicken breast mixed with white rice, or gently warm canned dog food to enhance its aroma and make it easier to swallow. Ensure fresh, clean water is available at all times.
Isolation and Disinfection Protocols
- Strict Quarantining: Keep the infected dog inside the home and away from all other dogs and cats for a minimum of 21 to 28 days. Do not allow the dog in public areas, dog parks, pet stores, or residential apartment dog-relief zones. Walk the dog exclusively on a leash in a private yard or low-traffic area away from other pets.
- Household Hygiene: Wash food and water bowls daily in hot, soapy water or a dishwasher. Clean toys, bedding, leashes, and hard surfaces using standard household disinfectants or a diluted bleach solution (1 cup of household bleach per gallon of water). The influenza virus has a lipid envelope that is easily destroyed by common detergents and quaternary ammonium compounds.
- Caregiver Sanitation: Wash your hands thoroughly with soap and warm water for at least 20 seconds after handling an ill pet, cleaning their bowls, or picking up their waste. Change clothing before interacting with other uninfected pets in the household if you have been in direct contact with the sick dog.
Vaccination Guidelines
Vaccination is a key tool for preventing canine influenza and reducing the severity of illness during outbreaks.
- Bivalent Vaccine: Modern canine influenza vaccines are bivalent, meaning they contain killed viral antigens for both the H3N2 and H3N8 strains.
- Vaccination Schedule: The primary vaccination requires an initial dose followed by a booster injection 2 to 4 weeks later. Full protective immunity is established approximately 1 to 2 weeks after the second dose. Annual booster vaccinations are recommended for at-risk dogs.
- Lifestyle Risk Assessment: The vaccine is classified as a non-core vaccine. It is recommended for dogs that frequently interact with other dogs, such as those that visit boarding facilities, dog daycare centers, grooming salons, dog parks, or dog shows. While the vaccine may not completely prevent infection in every case, it significantly reduces viral shedding, shortens illness duration, and protects against severe complications like pneumonia.
References and Citations
- American Veterinary Medical Association (AVMA). Canine Influenza Background, Clinical Signs, and Prevention Guidelines. medlifeguide.com/references/avma-canine-influenza
- Centers for Disease Control and Prevention (CDC). Key Facts About Canine Influenza (Dog Flu) and H3N2/H3N8 Strains. medlifeguide.com/references/cdc-canine-influenza
- UC Davis School of Veterinary Medicine. Canine Influenza (Flu) Clinical Overview, Diagnosis, and Management. medlifeguide.com/references/ucdavis-canine-flu
- MSD Veterinary Manual. Canine Influenza (Flu) Etiology, Pathophysiology, and Clinical Features. medlifeguide.com/references/msd-vet-canine-flu
- Cornell University College of Veterinary Medicine Diagnostic Center. Canine Influenza Virus Diagnostic Testing, Serology, and Isolation Protocols. medlifeguide.com/references/cornell-vet-flu-protocols
Frequently Asked Questions (FAQs)
No, there is currently no evidence that canine influenza viruses (H3N2 or H3N8) can infect humans or spread from dogs to people.
Dogs diagnosed with or suspected of having H3N2 canine influenza should be strictly isolated from other animals for 21 to 28 days due to prolonged viral shedding.
No, human over-the-counter pain relievers like acetaminophen (Tylenol) or ibuprofen are highly toxic to dogs and can cause fatal liver or kidney failure. Always consult a veterinarian for safe, pet-specific medications.
While both cause coughing, canine influenza is caused by specific influenza viruses that frequently trigger higher fevers, severe lethargy, thick nasal discharge, and a higher risk of secondary pneumonia.
No, the Bordetella vaccine only protects against specific bacterial infections and does not provide immunity against canine influenza viruses. A specific bivalent canine influenza vaccine is required for flu protection.
About the Reviewer
Dr. Adam N. Khan, MD is a board-certified physician dedicated to delivering clear, evidence-based medical and clinical guidance for patients, caregivers, and pet owners. He has zero commercial conflicts of interest, financial disclosures, or pharmaceutical industry ties related to the topics discussed.